Long Ideas - Amarin Corp. (NASDAQ:AMRN) announced FDA approval of Vascepa last night, a milestone event for the company. Shares are trading lower in the pre-market, however, largely … Continue Reading
Read nowLong Ideas - Speculation on the future of Alzheimer’s treatments has been at the forefront of major pharma and biotech news this month. Pfizer (NYSE:PFE) and Elan’s (NYSE:ELN) … Continue Reading
Read now- Shares of Xenoport (NASDAQ:XNPT) continues to rise this week off of Monday’s announcement that the company began Phase I testing of its treatment for Relapsing-Remitting … Continue Reading
Read now- Celgene reported second quarter earnings this morning, and although revenues beat estimates, earnings fell short; the company had EPS of $0.82 while analysts expected $1.06. … Continue Reading
Read now- In a press release this morning Genetic Technologies (NASDAQ:GENE) announced that California has cleared the company’s breast cancer DNA test BrevaGen™ for sale into the … Continue Reading
Read now- Covidien (NYSE:COV) reported strong fiscal 3rd quarter results, with sales of $3 billion in-line with expectations. Importantly, margins and net income beat expectations and the … Continue Reading
Read now- Rumors percolated today – pushing QCOR down nearly $9/share – that a conference call to be hosted by a Broker-Dealer would feature an expert discussing … Continue Reading
Read now